/Align%20Technology%2C%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Despite Align Technology’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
/Cooper%20Companies%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Cooper Companies has lagged behind the broader market this year, yet Wall Street analysts remain strongly optimistic about the stock's future potential.
/Intuitive%20Surgical%20Inc%20location%20sign-by%20Sundry%20Photography%20via%20iStock.jpg)
Intuitive Surgical has outpaced the broader market, and analysts are cautiously optimistic about the stock's future.
/Hologic%2C%20Inc_%20logo%20outside%20building%20by-%20Tada%20Images%20via%20Shutterstock.jpg)
Hologic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s future.
/Intuitive%20Surgical%20Inc%20laptop-%20by%20monticello%20via%20Shutterstock.jpg)
Intuitive Surgical is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.
/Cooper%20Companies%2C%20Inc_%20sign%20on%20building-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Cooper Companies has significantly underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.
/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20logo-%20by%20T_Schneider%20via%20Shutterstock.jpg)
IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.
/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
Despite ResMed’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Intuitive%20Surgical%20Inc%20logo%20on%20phone-by%20Ralf%20Liebhold%20via%20Shutterstock.jpg)
Intuitive Surgical has outperformed the broader market by a wide margin over the past year, and analysts are moderately optimistic about the stock’s prospects.
/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Hologic has lagged the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.